The Fédération Equestre Internationale (FEI) has announced an adverse analytical finding involving a prohibited substance in a para-dressage horse and final decisions in two separate cases involving an endurance horse and a show jumping horse.
Samples taken at the CPEDI3* in Somma Lombardo, Italy, on June 19, from the horse para-dressage horse Dendros, ridden to six place by Matthias Klausener of Switzerland, have returned positive for the banned substance demecolcine.
Demecolcine, a rheumatic treatment and chemotherapy, is a banned substance under the FEI’s Equine Anti-Doping and Controlled Medication Regulations (EADCMRs).
The athlete has been provisionally suspended from the date of notification (July 27), and the horse has also been provisionally suspended for a two-month period.
Further details on the case are available online.
The FEI Tribunal has also issued final decisions in two prohibited substance cases.
The FEI Tribunal imposed a two-year suspension on the Uruguayan endurance rider Fernanda Villar, effective immediately. Samples taken from her horse LG Muneerah, winner of the CEI2* in Trinidad, Uruguay, on Aug. 8, 2015, returned positive for guanabenz, a sedative with analgesic effects that is banned under the EADCMRs.
The period of provisional suspension, which came into effect on Sept. 29, 2015, the date of notification, has been credited against the period of ineligibility, which will run through to June 22, 2017. The athlete is also fined CHF 2,000 and ordered to contribute CHF 1